Clinical Trial

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

Study acronym: SPeCTRuM
Recruiting
View on ClinicalTrials.gov →
Summary
This multicenter cross-sectional study will include a diverse population of adolescents and adults with CF. The overall Aim is to describe prevalence of diabetes microvascular complications and macrovascular surrogates in people with established CFRD.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-02-14; most recent amendment 2026-02-09.
Status change: Not Yet Recruiting → Recruiting 2026-01-20
Trial Details
NCT Number NCT06837181
Lead Sponsor Jaeb Center for Health Research
Collaborators: Cystic Fibrosis Foundation
Conditions Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes, Diabetes, Retinopathy, Neuropathy, Nephropathy, Blood Pressure, Cardiovascular Risk +1 more
Enrollment 200 participants
Start Date 2025-09-18
Primary Completion 2028-11-30 (estimated)
Study Completion 2028-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-10